Taniki Nobuhito

タニキノブヒト | Taniki Nobuhito

Affiliation and department：
Research theme for competitive and other funds (4)：

2022 - 2025 ”腸-肝臓-脳相関”で構成される自律神経回路による大腸癌の新規病態解明と治療開発
2020 - 2022 Development of a new treatment for primary sclerosing cholangitis with indigo naturalis
2018 - 2020 Mechanism of immune tolerance in the liver via gut-liver axis
2016 - 2019 Role of gut microbiota in the pathogenesis of primly sclerosing cholangitis

Papers (48)：

Masataka Ichikawa, Haruka Okada, Nobuhiro Nakamoto, Nobuhito Taniki, Po-Sung Chu, Takanori Kanai. The gut-liver axis in hepatobiliary diseases. Inflammation and regeneration. 2024. 44. 1. 2-2
安藤裕子, 中代幸江, 楮柏松, 杉本真也, 山田洋平, 長谷川康, 春日良介, 田淵貴也, 近藤まゆ子, 森川麗, et al. COVID-19を契機にAcute-on-chronic肝不全(ACLF)の回復期にGLP-2アナログを導入した腸管機能不全関連肝障害(IFALD)の一例. 肝臓. 2023. 64. Suppl.3. A911-A911
Sota Fujimori, Po-Sung Chu, Toshiaki Teratani, Yosuke Harada, Takahiro Suzuki, Takeru Amiya, Nobuhito Taniki, Ryosuke Kasuga, Yohei Mikami, Yuzo Koda, et al. IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis. JHEP Reports. 2023. 5. 7. 100757-100757
Masataka Ichikawa, Nobuhiro Nakamoto, Sharon Kredo-Russo, Eyal Weinstock, Iddo Nadav Weiner, Efrat Khabra, Noa Ben-Ishai, Dana Inbar, Noga Kowalsman, Ron Mordoch, et al. Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis. Nature Communications. 2023. 14. 1. 3261-3261
Yoichi Takimoto, Po-Sung Chu, Nobuhiro Nakamoto, Yuya Hagihara, Yohei Mikami, Kentaro Miyamoto, Rei Morikawa, Toshiaki Teratani, Nobuhito Taniki, Sota Fujimori, et al. Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis. iScience. 2023. 26. 3. 106220-106220

ｍore...

MISC (149)：

Ryosuke Kasuga, Po-Sung Chu, Nobuhito Taniki, Nobuhiro Nakamoto, Takanori Kanai. SERUM ALBUMIN LEVELS IMPROVE TRANSPLANT-FREE SURVIVAL PREDICTING PERFORMANCE OF CLIF-C ACLF SCORES IN CIRRHOTIC PATIENTS SUFFERED FROM AD/ACLF BEYOND 90 DAYS. HEPATOLOGY. 2022. 76. S914-S915
Nobuhito Taniki, Ryosuke Kasuga, Po-Sung Chu, Akihiro Yamaguchi, Hitomi Hoshi, Keisuke Ojiro, Fumihiko Kaneko, Nobuhiro Nakamoto, Takanori Kanai. PRIOR HISTORY OF LOCOREGIONAL THERAPY ASSOCIATES WITH TACE REFRACTORINESS IN PATIENTS WITH INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA. HEPATOLOGY. 2022. 76. S1403-S1403
岩崎栄典, 谷木信仁, 堀周太郎, 曽我茂樹. Percutaneous transhepatic gallbladder drainage for acute cholecystitis. 肝胆膵. 2022. 85. 4. 543-550
谷木信仁, 中本伸宏, 金井隆典. 肝癌局所療法の成績向上に向けた取り組み新規マイクロ波アブレーション(MWA)の治療成績向上に向けた取り組み. 肝臓. 2022. 63. Suppl.3. A717-A717
肱岡悠子, 戸張真紀, 永松洋明, 丸山紀史, 黒田英克, 畑中健, 小宮山泰之, 堀田直樹, 谷木信仁, 吉田英雄, et al. 肝細胞癌患者を対象としたマイクロ波焼灼術とラジオ波焼灼術の有効性,安全性に関する検討. 肝臓. 2022. 63. Suppl.3. A754-A754

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page